Literature DB >> 10626737

Polymorphism in the regulatory region located more than 1.1 kilobases 5' to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene.

T V Hviid1, S Sørensen, N Morling.   

Abstract

The non-classic Human Leucocyte Antigen class Ib molecule, HLA-G, is expressed on the invasive, extra-villous cytotrophoblast in human placenta. HLA-G protects against natural killer (NK)-cell-mediated lysis and may modulate the secretion of cytokines. Aberrant expression of HLA-G has been reported in certain disorders of pregnancy. We have studied the DNA sequences of the putative regulatory region located more than 1.1 kilobases 5' from the start site of transcription (a 244 bp HindIII/EcoRI fragment) of the HLA-G gene and of the promoter region to detect any possible polymorphism. We detected one nucleotide substitution in the HindIII/ EcoRI region and one in the promoter region in the alleles G*01012, G*01013, G*0104, and G*0105N compared to G*01011. Several nucleotide substitutions were detected in the region between the 1.1 kb 5' regulatory region and the promoter region. Alleles can be divided into two groups based on the detected polymorphism. The nucleotide substitutions may have implications for the binding of nuclear factors to the regulatory regions. To our knowledge this is the first study of any polymorphism in the 5'-flanking sequences to the HLA-G gene. Further studies are needed to elucidate the exact impact of the detected polymorphism on levels or developmental regulation of HLA-G expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626737     DOI: 10.1016/s0198-8859(99)00130-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

1.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

Review 2.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 3.  Stranger in a strange land.

Authors:  Joan S Hunt
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

4.  The HLA-G genotype is associated with IL-10 levels in activated PBMCs.

Authors:  Roberta Rizzo; Thomas Vauvert F Hviid; Marina Stignani; Alessandra Balboni; Maria Teresa Grappa; Loredana Melchiorri; Olavio R Baricordi
Journal:  Immunogenetics       Date:  2005-04-02       Impact factor: 2.846

5.  Variation in the HLA-G promoter region influences miscarriage rates.

Authors:  Carole Ober; Carrie L Aldrich; Inna Chervoneva; Christine Billstrand; Fedik Rahimov; Heather L Gray; Terry Hyslop
Journal:  Am J Hum Genet       Date:  2003-04-29       Impact factor: 11.025

6.  HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms.

Authors:  Thomas Vauvert F Hviid; Roberta Rizzo; Ole B Christiansen; Loredana Melchiorri; Anette Lindhard; Olavio R Baricordi
Journal:  Immunogenetics       Date:  2004-05-07       Impact factor: 2.846

Review 7.  HLA-G and its role in implantation (review).

Authors:  Roumen G Roussev; Carolyn B Coulam
Journal:  J Assist Reprod Genet       Date:  2007-07-14       Impact factor: 3.412

8.  HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission.

Authors:  Felix O Aikhionbare; K Kumaresan; Falah Shamsa; Vincent C Bond
Journal:  AIDS Res Ther       Date:  2006-10-23       Impact factor: 2.250

Review 9.  Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction.

Authors:  Line Lynge Nilsson; Snezana Djurisic; Thomas Vauvert F Hviid
Journal:  Front Immunol       Date:  2014-05-13       Impact factor: 7.561

Review 10.  Transcriptional and posttranscriptional regulations of the HLA-G gene.

Authors:  Erick C Castelli; Luciana C Veiga-Castelli; Layale Yaghi; Philippe Moreau; Eduardo A Donadi
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.